Listed

Phio Pharmaceuticals Corp.

PHIONasdaqCIK 1533040HealthcareFiscal year ends Dec 31

Reports and events: 316 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Phio Pharmaceuticals Corp., Reports and events
FiledFormWhat it isAccession number
2024-12-1908:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-24-008833
2024-11-1416:49 ET10-QQuarterly reportPeriod 2024-09-300001683168-24-008120
2024-11-1416:47 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-24-008118
2024-11-0710:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-24-007713
2024-08-1417:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-24-005707
2024-08-1416:45 ET10-QQuarterly reportPeriod 2024-06-300001683168-24-005706
2024-08-0108:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001683168-24-005194
2024-07-2616:30 ETS-1Registration statement0001683168-24-005092
2024-07-2416:30 ET8-K8.01 Other events0001683168-24-005049
2024-07-1216:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-24-004800
2024-07-0508:01 ET8-K1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-24-004683
2024-07-0217:00 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-24-004619
2024-06-2116:45 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001683168-24-004417
2024-05-2817:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-24-003849
2024-05-1716:45 ETS-1Registration statement0001683168-24-003624
2024-05-1709:00 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-24-003598
2024-05-0917:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-24-003178
2024-05-0917:20 ET10-QQuarterly reportPeriod 2024-03-310001683168-24-003175
2024-05-0817:02 ETDEF 14AProxy statementPeriod 2024-06-170001683168-24-003113
2024-04-0207:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-24-002050
2024-04-0116:31 ET10-KAnnual reportPeriod 2023-12-310001683168-24-002021
2024-01-2617:00 ET8-K3.01 Delisting notice0001683168-24-000489
2023-12-1916:52 ETS-1Registration statement0001683168-23-008964
2023-12-0817:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-23-008732
2023-11-0916:40 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-23-007815
2023-11-0916:31 ET10-QQuarterly reportPeriod 2023-09-300001683168-23-007809
2023-08-2107:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-23-005923
2023-08-1016:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-23-005515
2023-08-1016:30 ET10-QQuarterly reportPeriod 2023-06-300001683168-23-005514
2023-07-2616:30 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001683168-23-005094
2023-06-0916:30 ETDEF 14AProxy statementPeriod 2023-07-200001683168-23-004045
2023-06-0817:00 ETS-1Registration statement0001683168-23-004016
2023-06-0216:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-23-003863
2023-05-2407:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-23-003671
2023-05-1607:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-23-003433
2023-05-1117:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-23-003214
2023-05-1117:01 ET10-QQuarterly reportPeriod 2023-03-310001683168-23-003213
2023-04-2817:07 ETS-1Registration statement0001683168-23-002765
2023-04-2017:22 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-23-002559
2023-04-2014:53 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001683168-23-002542
2023-04-1807:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-23-002493
2023-04-1717:25 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-23-002488
2023-03-2217:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-23-001679
2023-03-2217:00 ET10-KAnnual reportPeriod 2022-12-310001683168-23-001678
2023-03-1017:10 ET8-K8.01 Other events0001683168-23-001424
2023-02-2207:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001683168-23-001075
2023-02-1307:30 ET8-K8.01 Other events0001683168-23-000781
2023-01-2508:35 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-23-000307
2023-01-0617:00 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-23-000098
2022-12-2116:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-22-008584

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.